VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JXN-PA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JXN-PAJackson Financial Inc.
$25.50$1.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksJXN-PAQuarterly Financials

Jackson Financial Inc. (JXN-PA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Jackson Financial Inc. (JXN-PA) quarterly income statement — complete revenue, gross profit & net income history

JXN-PA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue2.9B1.99B1.35B-483M3.72B158M2.09B1.2B-359M905M2.59B431M-754M-535M2.97B6.7B2.21B1.69B1.56B244M
Revenue Growth %-22.05%1158.23%-35.55%-140.25%1137.05%-82.54%-19.28%178.42%52.39%269.16%-12.81%-93.57%-134.13%-131.71%90.03%2647.13%-59.48%213.92%--
Medical Costs & Claims0204M977M-1.55B2.91B-1.07B1.74B57M-2.08B2B-1.71B-1.86B525M-231M-329M1.82B-1.26B9.1M426M-39M
Medical Cost Ratio %0%10.26%72.42%321.12%78.06%-679.75%82.99%4.75%580.22%220.66%-65.79%-431.55%-69.63%43.18%-11.06%27.09%-56.95%0.54%27.22%-15.98%
Gross Profit01.78B372M1.07B817M1.23B356M1.14B1.72B-1.09B4.3B2.29B-1.28B-304M3.3B4.89B3.47B1.68B1.14B283M
Gross Margin %0%89.74%27.58%-221.12%21.94%779.75%17.01%95.25%-480.22%-120.66%165.79%531.55%169.63%56.82%111.06%72.91%156.95%99.46%72.78%115.98%
Gross Profit Growth %-100%44.81%4.49%-6.56%-52.61%212.82%-91.72%-50.11%234.79%-259.21%30.15%-53.12%-136.89%-118.11%189.99%1626.86%-19.99%180.26%--
Operating Expenses02.14B300M879M834M852M935M825M821M863M797M826M775M649M778M748M854M929.9M887M821M
OpEx / Revenue %0%107.75%22.24%-181.99%22.4%539.24%44.67%68.75%-228.69%95.36%30.74%191.65%-102.79%-121.31%26.16%11.16%38.66%55.11%56.68%336.48%
Depreciation & Amortization000000000000002M3M3M2.6M4M2M
Combined Ratio %0%118.01%94.66%139.13%100.46%-140.51%127.66%73.5%351.53%316.02%-35.06%-239.91%-172.41%-78.13%15.1%38.25%-18.29%55.65%83.9%320.49%
Operating Income-415M-358M72M189M-17M380M-579M318M903M-1.96B3.5B1.47B-2.05B-953M2.52B4.14B2.61B748.3M252M-538M
Operating Margin %-14.3%-18.01%5.34%-39.13%-0.46%240.51%-27.66%26.5%-251.53%-216.02%135.06%339.91%272.41%178.13%84.9%61.75%118.29%44.35%16.1%-220.49%
Operating Income Growth %-2341.18%-194.21%112.44%-40.57%-101.88%119.44%-116.53%-78.29%143.96%-105.14%38.69%-64.61%-178.61%-227.36%901.98%869.33%-27.13%558.52%--
EBITDA-415M-333M97M214M8M405M-554M344M928M-1.92B3.53B1.49B-2.03B-913M2.53B4.14B2.62B750.9M256M-536M
EBITDA Margin %-14.3%-16.75%7.19%-44.31%0.21%256.33%-26.47%28.67%-258.5%-212.15%136.14%346.4%268.7%170.65%84.97%61.79%118.42%44.5%16.36%-219.67%
Interest Expense25M25M25M25M25M25M25M26M25M35M49M28M28M40M29M24M20M18M6M7M
Non-Operating Income0-25M-25M-25M-25M-25M-25M-26M-25M-35M-28M-28M-28M-40M-29M-24M-20M-18M-6M-7M
Pretax Income-415M-358M72M189M-17M380M-579M318M903M-1.96B3.5B1.47B-2.05B-953M2.52B4.14B2.61B748.3M252M-538M
Pretax Margin %-14.3%-18.01%5.34%-39.13%-0.46%240.51%-27.66%26.5%-251.53%-216.02%135.06%339.91%272.41%178.13%84.9%61.75%118.29%44.35%16.1%-220.49%
Income Tax20M-172M-19M4M1M22M-113M36M101M-395M712M245M-558M-235M657M845M388M87.3M-16M-54M
Effective Tax Rate %-4.82%48.04%-26.39%2.12%-5.88%5.79%19.52%11.32%11.18%20.2%20.33%16.72%27.17%24.66%26.02%20.42%14.85%11.67%-6.35%10.04%
Net Income-435M-204M76M179M-24M345M-469M275M795M-1.56B2.77B1.22B-1.5B-710M1.88B3.26B2.19B585.3M206M-540M
Net Margin %-14.99%-10.26%5.63%-37.06%-0.64%218.35%-22.41%22.92%-221.45%-172.27%106.94%282.37%198.54%132.71%63.18%48.68%99.32%34.69%13.16%-221.31%
Net Income Growth %-1712.5%-159.13%116.2%-34.91%-103.02%122.13%-116.91%-77.4%153.11%-119.58%47.58%-62.7%-168.23%-221.31%812.14%704.26%-25.17%673.18%--
EPS (Diluted)-6.19-3.060.922.34-0.474.45-6.233.439.94-19.8233.3514.21-18.11-8.4816.8332.5622.516.192.18-5.72
EPS Growth %-1217.02%-168.76%114.77%-31.78%-104.73%122.45%-118.68%-75.86%154.89%-133.73%98.16%-56.36%-180.45%-237%672.02%669.23%-27.46%683.54%--
EPS (Basic)-6.21-3.070.932.34-0.474.50-6.273.4510.04-19.8233.6614.58-18.11-8.4817.3833.7723.456.362.18-5.72
Diluted Shares Outstanding70.28M70.28M70.28M71.94M75.13M75.13M77.08M77.08M78.87M80.72M82.82M84.75M82.65M83.7M87.9M89.17M89.96M94.47M94.46M94.46M